Based on COVAX’s initial first-round allocation plan, UNICEF said the plan calls for 145 countries to receive doses to immunize around 3% of their populations, on average, starting in the first half of 2021. ———AMSTERDAM — The European Medicines Agency says it has received a request from Johnson & Johnson for its one-shot coronavirus vaccine to be authorized. But unlike those vaccines, the J&J vaccine requires only a single dose. Preliminary results from a large trial in the U.S., Latin America and South Africa suggested J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19. The shot is also being vetted by the U.S. Food and Drug Administration, whose expert panel will meet on Feb. 26 to publicly debate the vaccine’s data.

Source: Daily Sun February 16, 2021 13:30 UTC